Platelet Associated u-PA Up-regulates u-PA Synthesis by Endothelial Cells

Summary Adhesion of platelets to endothelium has been shown to induce important changes in endothelial properties. In this study, we examined the effect of platelet-endothelial cell interactions on the expression of urokinase-type plasminogen activator (u-PA) by human microvascular endothelial cells. After incubation of endothelial cells with platelets, a dose-dependent increase in the expression of u-PA Ag was observed and reached a plateau for a ratio of 300 platelets per endothelial cells. The u-PA Ag upregulation resulted from an increase in u-PA mRNA that originated from a synthesis by endothelial cells since no u-PA mRNA was detected in platelets. The platelet-induced u-PA synthesis was inhibited when the endothelial cells were pre-treated with phospholipase C to remove the u-PA receptor, or when the platelets were incubated with an antibody that blocks the binding of u-PA to u-PAR. Taken together, these data indicate that u-PA present on the platelet surface interacts with u-PAR on the endothelial cells and induces the u-PA synthesis. This mechanism may represent a physiological control of platelet-mediated intravascular fibrin deposition.

[1]  D. Dixon,et al.  Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis , 2001, The Journal of cell biology.

[2]  J. Zhang,et al.  Urokinase-type plasminogen activator up-regulates its own expression by endothelial cells and monocytes via the u-PAR pathway. , 2001, Thrombosis research.

[3]  T. Podor,et al.  Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. , 2001, Blood.

[4]  M. Shibuya,et al.  Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Dignat-George,et al.  Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. , 1997, Tissue antigens.

[6]  V. Gurewich,et al.  Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator. , 1997, Blood.

[7]  P. Carmeliet,et al.  Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  V. Gurewich,et al.  Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes. , 1996, Blood.

[9]  F. Lanza,et al.  Quantitation of hemopoietic cell antigens in flow cytometry. , 1996, European journal of histochemistry : EJH.

[10]  M. Johnstone,et al.  The Selective Uptake of High Molecular Weight Urokinase-type Plasminogen Activator by Human Platelets , 1995 .

[11]  P. Carmeliet,et al.  Physiological consequences of loss of plasminogen activator gene function in mice , 1994, Nature.

[12]  V. Gurewich,et al.  Pro‐urokinase and prekallikrein are both associated with platelets , 1993, FEBS letters.

[13]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[14]  D. Belin,et al.  The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.

[15]  B. Binder Influence of urokinase on cell proliferation and invasion. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[16]  L. Harker,et al.  Demonstration of single chain urokinase-type plasminogen activator on human platelet membrane. , 1989, Blood.

[17]  F. Blasi Surface Receptors for Urokinase Plasminogen Activator , 1988 .

[18]  D. Rifkin,et al.  Cell-associated plasminogen activation: regulation and physiological functions. , 1988, Annual review of cell biology.

[19]  F. Blasi,et al.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors , 1987, The Journal of cell biology.

[20]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[21]  V. Gurewich,et al.  Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. , 1984, The Journal of clinical investigation.

[22]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.